Ownership Summary
Quarter ending 30 Jun, 2026
Clearmind Medicine Inc. (NASDAQ:CMND) showed up in the 13F filings of 6 institutional investors as of June 2026.
- Their combined ownership stood at 385.6% of outstanding shares in June 2026, up from 35.4% in March 2026.
- They increased total shares held in CMND by 0.0% quarter over quarter, and investors in Clearmind Medicine decreased 33.33% from a year ago.
- Of these 6 funds, 6 grew their exposure to Clearmind Medicine, 0 cut back, and 0 maintained positions.
- Institutional investors collectively held 49.01K shares in Clearmind Medicine as of June 2026, up by 49.01K shares quarter on quarter, and up 34.31K shares year over year.
- HRT FINANCIAL LP leads ownership in CMND with 35.14K shares as of June 30, 2026, equal to 276.52% of outstanding shares.
- The biggest buyers of Clearmind Medicine for the quarter ending June 2026 included HRT FINANCIAL LP (35.14K), CITADEL ADVISORS LLC (11.71K), AdvisorShares Investments LLC (1.17K), Morgan Stanley (700), Royal Bank Of Canada (287).
- Per Business Quant, the top 6 investors in CMND for the quarter ending June 2026 include HRT FINANCIAL LP (35.14K), CITADEL ADVISORS LLC (11.71K), AdvisorShares Investments LLC (1.17K), Morgan Stanley (700), Royal Bank Of Canada (287), Caitong International Asset Management Co., Ltd (1).